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We have recently reported that HIV-1 Nef down-regulates the cell surface expression of major histocompatibility complex
class I (MHC-I) molecules. MHC-I molecules are one of the predominant cellular proteins associated with HIV-1 virions.
Wild-type or nef-mutated HIV-1 virions were analyzed by immunoelectronic microscopy and Western blot for particle-
associated MHC-I molecules. The number of MHC-I molecules was significantly higher in HIV-1 virions produced in the
absence of Nef than in wild-type virions, indicating that Nef affects the incorporation of MHC-I molecules into virions. Wild-
type HIV particles have been shown to be more infectious than Nef0 viruses. This difference was maintained when Nef/
and Nef0 virions devoid of MHC-I molecules were produced in Daudi-CD4 cells. Therefore, the enhancement of virion
infectivity and the down-regulation of MHC-I represent independent biological properties of Nef. q 1997 Academic Press
The nef gene is present in most strains of HIV and Whereas many cellular proteins are excluded during
SIV, indicating that the protein is important for in vivo the assembly process of HIV-1 particles, MHC-I and
virus propagation. The Nef protein is a 27- to 30-kDa MHC-II molecules have been consistently detected at
myristoylated product expressed early in the viral cycle. the virion surface (19–21). The estimation of the number
It is predominantly localized in the cytoplasm and associ- of ß2-microglobulin molecules incorporated into virions
ated with membranes. In SIVMAC239-infected rhesus mon- suggested that this protein significantly outnumbers the
keys, Nef expression is necessary for maintaining high molecules of envelope glycoprotein (600 versus 200, re-
virus loads and for inducing AIDS (1). The molecular spectively) (19). The consequences of the presence of
basis of this phenomenon, as well as those of the differ- virion-incorporated MHC-I molecules on HIV-1 replica-
ent activities attributed to Nef in vitro remain imperfectly tion and pathogenesis remain unclear. The inhibition of
understood. The expression of Nef in HIV-1-infected cells viral replication by anti-MHC-I mAbs suggested that vi-
induces (i) the down-regulation of cell surface expression rion-associated cellular proteins are involved in the infec-
of CD4 and major histocompatibility complex class I tion process (19, 22–24). On the other hand, the produc-
(MHC-I) molecules by selective endocytosis and degra- tion of infectious HIV-1 virus particles in cells devoid
dation in the lysosomes (2–5); (ii) the modification of of cell surface MHC-I molecules indicated that virion-
T cell activation pathways (6, 7), probably through the associated MHC-I molecules are not required for the
association with cellular kinases (8–10); and (iii) the pro- infection of target cells (23). Whether the presence of
duction of virus particles with enhanced infectivity (11, MHC-I into virions increases particle infectivity remains,
12). This latter effect of Nef appears as a consequence however, unknown.
of an imprinting of the virus particles which takes place We have recently reported that Nef modulates MHC-I
in the virus-producing cells and results in an increased surface expression by endocytosis (5). In the presence
efficiency of the reverse transcription in target cells (13 – of Nef, MHC-I synthesis and transport through the endo-
15). The molecular determinants of this imprinting have plasmic reticulum/ cis Golgi occurs normally. In contrast,
not yet been recognized. Candidate mechanisms could cell surface MHC-I molecules are rapidly internalized,
involve the incorporation of trace amounts of Nef in virus accumulate in endosomal vesicles, and are degraded in
particles (16, 17) and the phosphorylation of the matrix lysosomes (5). Since Nef reduces the number of MHC-I
protein by Nef in virus-producing cells (18). molecules present at the cell surface, we hypothesized
that virion-associated MHC-I molecules might be less
abundant in wild-type HIV-1 particles than in particles1 To whom reprint requests should be addressed. Fax: 33 (1) 45 68
89 40. E-mail: schwartz@pasteur.fr. produced in the absence of Nef. This hypothesis was
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confirmed by immunoelectronic microscopy and Western gesting an effect of Nef on MHC-I incorporation into
virions.blotting. The difference in particles MHC-I content be-
A more accurate quantification of the levels of MHC-Itween nef/ and nef0 viruses could therefore be responsi-
molecules incorporated into HIV and HIVDnef virionsble for the difference of virion infectivity. Using virus pro-
was performed on purified virus particles. Supernatantduced in human cells which do or do not express MHC-
of MT4 cells was collected 2 or 3 days after infectionI at the cell surface, we observed that MHC-I-positive
with wild-type HIV or HIVDnef, and the number of virusand -negative wild-type HIV-1 particles display identical
particles was estimated by measuring the p24 proteininfectivities. Moreover, the differences of virion infectivity
by ELISA. Virus particles corresponding to 500 ng of p24between wild-type and Nef0 viruses were retained even
were pelleted by ultracentrifugation, resuspended inin the absence of MHC-I molecules into virus particles.
PBS, and spread on a Formvar carbon film on electronWe concluded that the enhancement of virion infectivity
microscope nickel grids. Grids were incubated with anti-induced by Nef is not a direct consequence of the incor-
MHC-I mAbs recognizing either the heavy chain (HC.10)poration of MHC-I molecules in HIV-1 virions.
or a conformational epitope exposed in heavy chain–ß2-
Virion-associated MHC-I molecules are less abundant microglobulin heterodimers (B9.12.1) (25). As a positive
in Nef/ than in Nef0 virus particles control, virions were incubated with the 110-H anti-gp120
mAb (13). Grids were then incubated with a goat anti-
We studied the presence of MHC-I molecules in HIV-
mouse IgGs conjugated with 10-nm gold particles and a
1 virions by immunoelectronic microscopy. HIV and HIV- negative staining was performed with phosphotungstic
Dnef viruses were produced in HeLa cells by transfect- acid. In both wild-type HIV and HIVDnef preparations a
ing the molecular clones pNL43-2 and pNL43-2Xho, large fraction of the particles was stained with the anti-
which carries a frame shift mutation near the 5* end of MHC-I mAb as well as with the anti-gp120 mAb (see
the nef gene (13). MT4 lymphoid cells, which are highly Figs. 2A and 2B for examples of staining of HIV virions).
sensitive to HIV infection and produce high levels of vi- Control stainings made without the first mAb indicated
rus, were infected with HIV or HIVDnef viruses. Cells that the staining procedure was antigen-specific (not
were fixed 2 days later, before the occurrence of the shown). Since viral preparations may contain nonviral
virus-associated cytopathic effect, and ultrathin cryosec- material (26), noninfected cells were examined for the
tions were performed and subjected to the immunogold presence of cellular debris (Fig. 2C). Some membranous
labeling procedure, as described in the legend of Fig. vesicles, with size and morphology easily distinguishable
1. Sections were incubated with the HC.10 monoclonal from those of the virus-like structures, were rarely ob-
antibody (mAb), which recognizes the heavy chain of HLA served in the supernatants of uninfected (Fig. 2C) or in-
A, B, and C haplotypes, followed by staining with goat fected cells. This indicated that viral preparations con-
anti-mouse IgGs conjugated with 10-nm gold particles. tained low amounts of contaminating cellular debris. The
Electron microscopy observation revealed gold particles number of gold particles was scored on 50 to 100 HIV
at the cell surface of both noninfected (Fig. 1A) and HIV- or HIVDnef virions (Table 1). Staining with the 110-H anti-
infected MT4 cells (Figs. 1B and 1C). Controls made with- gp120 mAb showed no significant difference between
out or with a nonrelevant first mAb showed no back- HIV and HIVDnef virions. This result confirmed that Nef
ground staining (not shown). Numerous particle-like does not alter the incorporation of gp120 into virions, as
structures budding at the cell surface and free virions in previously observed by immunoprecipitation and West-
the intercellular spaces were observed in HIV-infected ern blot analysis (13, 27). Both anti-MHC-I mAbs showed
cells and were absent in noninfected cells. Gold particles a significant difference in the number of virus-associated
were detected on both HIV and HIVDnef viruses, confirm- gold particles between HIV and HIVDnef. In the absence
ing the presence of MHC-I molecules in HIV-1 virions of Nef, two- to threefold more MHC-I molecules were
(19). Although no attempt was made to quantify the label- incorporated into HIV-1 particles. This difference is con-
ing intensity on ultrathin cryosections, the density of sistent with the two- to threefold reduction of MHC-I
MHC-I labeling appeared greater on HIVDnef (Fig. 1C) staining measured by flow cytometry at the surface of
Nef-expressing cells (5).particles than on wild-type HIV particles (Fig. 1B), sug-
FIG. 1. Detection of MHC-I molecules on HIV- and HIVDnef-infected MT4 cells by immunoelectronic microscopy. Noninfected (A), HIV-infected
(B), and HIVDnef-infected (C) MT4 cells were fixed with 4% paraformaldehyde (PFA) and 0.1% glutaraldehyde in 0.1 M Sorensen buffer for 30 min,
concentrated in agar, and postfixed with 0.5% uranyl acetate for 1 hr. Cells were then deshydrated in ethanol and embedded in Lowicryl K4M at
progressive low temperatures (047 to 0357). Lowicryl thin sections were collected on nickel grids, treated 10 min in PBS–10 mM NH4Cl, washed
in PBS, and incubated for 20 min for blocking with 1% goat serum in PBS–1% bovine serum albumin (BSA). Grids were then incubated for 1 hr at
room temperature on a drop of a 10 mg/ml solution of the anti-MHC-I mAb HC.10 (kindly provided by F. Lemonnier, Institut Pasteur) in PBS–0.1%
BSA. After five washes in PBS – 0.1% BSA, the grids were incubated for 1 hr at room temperature with a 1:25 dilution of anti-mouse IgG / IgM
antibodies conjugated with 10-nm gold particles (Amersham Life Science) in PBS–0.1% BSA. Sections were constrasted by a 3-min staining with
uranyl acetate. Bar, 100 nm.
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MHC-I molecules were also quantified in HIV- and
HIVDnef-purified virions by Western blot analysis. The
supernatant of MT4 cells was collected 2 days after infec-
tion with HIV or HIVDnef, analyzed for p24 content, and
virions corresponding to 25 ng of p24 were purified by
ultracentrifugation. Immunoblotting with anti-Gag mAbs
indicated that equivalent amounts of viral material were
loaded on the HIV and HIVDnef lanes (Fig. 3, left panel,
MT4). The HC.10 anti-MHC-I mAb detected the 46-kDa
MHC-I heavy chain in both HIV and HIVDnef virions, but
not in the ultracentrifugated supernatant of noninfected
MT4 cells, indicating that the viral pellet did not contain
a significant level of cellular debris or vesicles bearing
MHC-I molecules (Fig. 3, right panel, MT4). Signal quanti-
fication indicated that Nef/ particles contained three- to
fourfold fewer MHC-I molecules than Nef0 viruses, con-
firming that the incorporation of MHC-I molecules into
virions was reduced in the presence of Nef.
It has been recently reported that approximatively 10
Nef molecules per particle can be detected in purified
HIV-1 preparations, either as 27-kDa full-length pro-
teins or as 20-kDa truncated fragments (16, 17). A pos-
sible explanation for the reduced packaging of MHC-
I molecules is that virus-associated Nef impairs the
incorporation of MHC-I. However, since Nef induced
equivalent reduction of both cell surface and virion-
associated MHC-I molecules, it is likely that the re-
duced packaging of MHC-I molecules is a conse-
quence of the presence of fewer MHC-I molecules at
the surface of virus-producing cells rather than a selec-
tive exclusion of MHC-I molecules from particles con-
secutive to the incorporation of Nef.
Virion-associated MHC-I molecules and virus
infectivity
We examined whether the enhancement of virus parti-
cle infectivity induced by Nef was a consequence of the
reduction in the number of MHC-I molecules incorpo-
rated into virions. This study was achieved by comparing
the infectivity of HIV and HIVDnef particles produced on
either MHC-I-positive or MHC-I-negative cells.
We used the human B lymphocytic cell line Daudi, in
which a mutation in the ß2-microglobulin gene abrogates
MHC-I surface expression (28). To allow HIV-1 infection,
mg/ml solution of the anti-gp120 mAb 110.H (a gift of Franc¸ois Traincart,
Institut Pasteur) (A) or of the anti-MHC-I mAb HC.10 (B), in PBS–1%
BSA–0.1% gelatin (PBG) for 1 hr at room temperature. After five washes
FIG. 2. Detection of gp120 and MHC-I molecules on purified HIV in PBG, the grids were incubated with a 1:25 dilution of anti-mouse
virions by immunoelectronic microscopy. Supernatants from HIV-in- IgG / IgM antibodies conjugated with 10-nm gold particles in PBG.
fected (A and B) and from noninfected (C) MT4 cells were ultracentri- The grids were washed and negatively stained. Grids were examined
fuged and the pellets were resuspended in PBS. Nickel grids previously in a Jeol 1200 EX II electronic microscope at an accelerating voltage
coated with a Formvar carbon film were laid on the virus suspension of 80 kV. Virus-like structures were detected in supernatants of HIV-
for 3 min and fixed with PBS–4% PFA–0.1% glutaraldehyde for 20 min infected cells only (A and B), whereas rare cellular debris and membra-
at room temperature. Grids were then treated 10 min in PBS–10 mM nous vesicles were observed in both HIV-infected and noninfected (C)
NH4Cl, blocked with PBS–1% BSA for 10 min, and incubated with a 10 MT4 cells. Bar, 50 nm.
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TABLE 1
Quantification of MHC-I Molecules on HIV and HIVDnef Virus Particles
Number of gold particles per virion (mean { SD)
mAb Specificity HIV HIVDnef P
110.H gp120 2.4 { 2.4 (n  36) 3 { 2.4 (n  52) 0.23
HC.10 MHC-I 1.8 { 1.2 (n  67) 5 { 2.6 (n  61) 0.0001
B.9.12.1 MHC-I 1.8 { 1.8 (n  79) 3.9 { 3.4 (n  80) 0.0001
Note. Grids coated with HIV and HIVDnef were prepared as indicated in Fig. 2 and the number of gold particles per virion was scored on the
indicated numbers of particles (n). For each mAb, means were compared by using a Student t test for unpaired values (P values are indicated on
the right column).
Daudi cells were stably transduced with a CD4-encoding in culture supernatants were analyzed by Western blot,
as described previously for MT4 cells. As shown in Fig.retroviral vector and CD4-positive Daudi cells were se-
lected by panning with an anti-CD4 mAb. CD4 expression 3, the amount of p24 in virus preparation from Daudi-CD4
cells was equivalent to that from MT4 cells. However, nowas verified on the selected cell population by flow cy-
tometry (not shown). Daudi-CD4 cells were then infected signal was detected with the HC.10 mAb, indicating that
MHC-I molecules were absent in HIV-1 particles pro-with either HIV or HIVDnef, and virus particles released
duced in Daudi-CD4 cells.
The relative particle infectivity (RPI, in PFU/ng of p24)
can be expressed as the ratio of the number of infectious
events scored on the P4 (HelaCD4-LTRLacZ) indicator
cell line (in PFU/ml) to the p24 content (in ng/ml) (13).
MT4 and Daudi-CD4 cells were infected with equivalent
inputs (0.1 PFU per cell) of HIV or HIVDnef. Virus produc-
tion in culture supernatants was monitored daily by mea-
suring the p24 contents (Fig. 4, left panels) and the infec-
tious titers (Fig. 4, middle panels). The relative particle
infectivity is shown in Fig. 4, right panels. In MT4 cells,
consistently with our previous observations (13), the RPI
was 3- to 10-fold lower for HIVDnef (peak value 150 PFU/
ng of p24) than for HIV (peak value 1600 PFU/ng of p24).
Daudi-CD4 cells were highly sensitive to HIV-1 infection.
Syncitia appeared within 24 hr and viral replication was
associated with a massive cytopathic effect (95% of
FIG. 3. Western blot analysis of MHC-I incorporation into HIV-1 and cell mortality at Day 5). HIV and HIVDnef produced equal
HIVDnef virions. Supernatants were collected from MT4 or Daudi-CD4
amounts of p24, with similar kinetics. The RPI reachedcell cultures 2 or 3 days after infection with HIV-1 or HIVDnef. Viruses
1400 PFU/ng of p24 for wild-type HIV. Similar RPIs werewere pelleted by ultracentrifugation (15 min at 60,000 rpm in a Beckman
thus observed when wild-type HIV is produced in cellsTL100 centrifuge). An identical volume of supernatant from noninfected
MT4 cells was centrifuged as a control (lane 0). Pellets were resus- that do or do not express MHC-I molecules, indicating
pended in lysis buffer (20 mM HEPES–150 mM NaCl–0.5% Triton). that the incorporation of MHC-I molecules into virions
Proteins corresponding to 25 ng of p24 were separated on a 12%
does not increase particle infectivity. In Daudi-CD4 cells,polyacrylamide gel electrophoresis (PAGE) and transferred to a nitro-
the RPI was 10- to 60-fold lower for HIVDnef (peak valuecellulose filter (Hybond C super, Amersham Life Science) using a semi-
at 50 PFU/ng) than for HIV particles. The loss of particledry electrotransfer apparatus (Bio-Rad). Filters were blocked 16 hr at
47 with 5% nonfat dry milk in PBS–0.5% Tween 20 and incubated in infectivity which characterizes Nef0 viruses is thus partic-
PBS –Tween–milk with either a cocktail of mAbs directed against the ularly marked in Daudi-CD4 cells. These results indi-
HIV-1 matrix and capsid proteins (0.5 mg/ml final dilution, left panel) or
cated that the positive effect of Nef on the infectivity ofwith the HC.10 anti-MHC-I heavy chain mAb (1 mg/ml final dilution,
HIV-1 is not a consequence of the reduction of MHC-Iright panel). After three washes with PBS–Tween 0.1%, the filters were
incorporation into virions.incubated with a 1:2500 solution of horseradish peroxidase-conjugated
sheep anti-mouse IgGs (Amersham Life Science) in PBS–Tween–milk. The increased infectivity of HIV-1 particles produced
After three washes, bound peroxydase activity was revealed using the in Nef-expressing cells correlates with increased rates
ECL chemoluminescence kit (Amersham Life Science) and exposure
of proviral DNA synthesis in target cells. However, veryon Hyperfilm (Amersham Life Science). Data are representative of three
few structural differences have been detected betweenindependent experiments. Similar results were obtained with superna-
tants collected 2 or 3 days after infection. HIV and HIVDnef particles. In particular, virion-associ-
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FIG. 4. Replication of HIV-1 and HIVDnef in MT4 and Daudi cells. Daudi-CD4 (top panels) and MT4 cells (bottom panels) were infected overnight
by incubation with cell-free supernatants of HIV (white circles) and HIVDnef (black circles) at a m.o.i. of 0.1 PFU per cell. Viral replication was
monitored daily by measuring the p24 concentration by ELISA (left column) and the infectious titers on the P4 (HelaCD4-LTRlacZ) indicator cell line
as previously described (13) (middle column). Particle infectivity (right panel) was calculated as the number of PFU/ng of p24. Data are representative
of three independent experiments.
ated reverse transcriptase activity is not affected by Nef benefits to the virus by impairing the detection of HIV-1-
(13–15). The only differences described so far between infected cells by the immune system. The reduction of
HIV and HIVDnef particles are the small amounts of Nef the number of MHC-I molecules incorporated into virions
present in wild-type virions (16, 17) and, as shown in a may simply be a mark of the decreased number of MHC-
preliminary report by Mangasarian and Trono, a serine I molecules available for packaging at the surface of
phosphorylation of the matrix protein (MA) stimulated by virus-producing cells. Whereas anti-MHC-I antibodies in-
Nef (18). Here, we further document the differences be- hibit virus infection (19, 22–24) and efficiently precipitate
tween Nef/ and Nef0 virions by showing a significant virus particles (19) in vitro, it is unlikely that infected
modulation of the incorporation of a cellular protein into individuals develop anti-MHC-I antibodies in response
virions. The difference of the amounts of virion-associ- to infecting virus particles coated with foreign MHC-I
ated MHC-I molecules between HIV and HIVDnef is, molecules. Later on, infected cells produce virions bear-
however, not responsible for the enhancement of particle ing self-MHC-I molecules. An antiviral effect mediated
infectivity induced by Nef. A previous report has shown by anti-MHC-I antibodies is therefore questionable.
that virion-associated MHC-I molecules are not required Whether the virus gains any replicative advantage in vivo
for cell infection (23). We confirm and extend this obser- by decreasing the number of incorporated MHC-I mole-
vation by showing that MHC-I-positive and -negative cules by Nef is not known.
wild-type HIV virions are equally infectious.
Nef is crucial for in vivo viral replication and disease
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